These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35511031)

  • 1. Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19.
    Jacobs JL; Naqvi A; Shah FA; Boltz VF; Kearney MF; McVerry BJ; Ray P; Schaefer C; Fitzpatrick M; Methé B; Lee JS; Morris A; Mellors JW; Kitsios GD; Bain W
    J Infect Dis; 2022 Dec; 226(12):2089-2094. PubMed ID: 35511031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
    Jacobs JL; Naqvi A; Shah FA; Boltz VF; Kearney MF; McVerry BJ; Ray P; Schaefer C; Fitzpatrick M; Methé B; Lee J; Morris A; Mellors JW; Kitsios GD; Bain W
    medRxiv; 2022 Jan; ():. PubMed ID: 35043122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.
    Jacobs JL; Bain W; Naqvi A; Staines B; Castanha PMS; Yang H; Boltz VF; Barratt-Boyes S; Marques ETA; Mitchell SL; Methé B; Olonisakin TF; Haidar G; Burke TW; Petzold E; Denny T; Woods CW; McVerry BJ; Lee JS; Watkins SC; St Croix CM; Morris A; Kearney MF; Ladinsky MS; Bjorkman PJ; Kitsios GD; Mellors JW
    Clin Infect Dis; 2022 May; 74(9):1525-1533. PubMed ID: 34374761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
    Buetti N; Wicky PH; Le Hingrat Q; Ruckly S; Mazzuchelli T; Loiodice A; Trimboli P; Forni Ogna V; de Montmollin E; Bernasconi E; Visseaux B; Timsit JF
    Crit Care; 2020 Oct; 24(1):610. PubMed ID: 33066801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of transfusion-transmitted infection with severe acute respiratory syndrome coronavirus 2 from blood donors in Japan.
    Shinohara N; Ito M; Kai K; Kamo N; Owada T; Sobata R; Yamagishi N; Takahashi H; Ikeda Y; Sawai H; Furuta RA; Matsubayashi K; Hino I; Goto N; Satake M
    Transfusion; 2024 Jan; 64(1):116-123. PubMed ID: 38088084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
    J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.
    Olea B; Albert E; Torres I; Gozalbo-Rovira R; Carbonell N; Ferreres J; Poujois S; Costa R; Colomina J; Rodríguez-Díaz J; Blasco ML; Navarro D
    J Med Virol; 2022 Jan; 94(1):222-228. PubMed ID: 34449894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
    Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
    Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients.
    Costa R; Alberola J; Olea B; Gozalbo-Rovira R; Giménez E; Cuevas-Ferrando E; Torres I; Albert E; Carbonell N; Ferreres J; Sánchez G; Rodríguez-Díaz J; Blasco ML; Navarro D
    Sci Rep; 2022 May; 12(1):8273. PubMed ID: 35585163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minipool testing for SARS-CoV-2 RNA in United States blood donors.
    Bakkour S; Saá P; Groves JA; Montalvo L; Di Germanio C; Best SM; Grebe E; Livezey K; Linnen JM; Strauss D; Kessler D; Bonn M; Green V; Williamson P; Kleinman S; Stramer SL; Stone M; Busch MP;
    Transfusion; 2021 Aug; 61(8):2384-2391. PubMed ID: 34046906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity.
    Olea B; Albert E; Torres I; Gozalbo-Rovira R; Carbonell N; Ferreres J; Poujois S; Costa R; Colomina J; Rodríguez J; Blasco ML; Navarro D
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34087349
    [No Abstract]   [Full Text] [Related]  

  • 14. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Burrel S; Hausfater P; Dres M; Pourcher V; Luyt CE; Teyssou E; Soulié C; Calvez V; Marcelin AG; Boutolleau D
    Int J Infect Dis; 2021 Jan; 102():10-13. PubMed ID: 33115679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients.
    Järhult JD; Hultström M; Bergqvist A; Frithiof R; Lipcsey M
    Sci Rep; 2021 Mar; 11(1):7163. PubMed ID: 33785784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma SARS-CoV-2 RNA elimination and RAGE kinetics distinguish COVID-19 severity.
    Deng X; Gantner P; Forestell J; Pagliuzza A; Brunet-Ratnasingham E; Durand M; Kaufmann DE; Chomont N; Craig M
    Clin Transl Immunology; 2023; 12(11):e1468. PubMed ID: 38020729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.
    Chen PZ; Bobrovitz N; Premji ZA; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Aug; 10():. PubMed ID: 34414888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of paired upper and lower respiratory tract sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in patients with artificial airways.
    Kitt EM; Davis DH; Kerman C; Sammons JS; Handy LK; Gallagher E; O'Callaghan K; Harris RM; Coffin SE; Bell LM; Chiotos K
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1482-1484. PubMed ID: 33966664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
    Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.
    Solis M; Gallais F; Garnier-Kepka S; Lefebvre N; Benotmane I; Ludes PO; Castelain V; Meziani F; Caillard S; Collange O; Fafi-Kremer S
    J Clin Virol; 2022 Mar; 148():105120. PubMed ID: 35227970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.